| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0042 | 1 |